X4 Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 16.92 M | $12.41 M | 0.00% | 8.42% |
NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 14.99 M | $10.99 M | 0.00% | 7.46% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 11.06 M | $8.11 M | -1.34% | 5.51% |
VANGUARD GROUP INC | 02/11/2025 | 8.20 M | $6.02 M | -2.84% | 4.08% |
02/14/2025 | 7.31 M | $5.36 M | 100.00% | 3.64% | |
ORBIMED ADVISORS LLC | 02/14/2025 | 7.13 M | $5.23 M | 0.00% | 3.55% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 02/14/2025 | 4.94 M | $3.62 M | 6.43% | 2.46% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.50 M | $2.57 M | 1.44% | 1.74% |
AXA S.A. | 02/14/2025 | 3.07 M | $2.25 M | -0.16% | 1.53% |
ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 2.55 M | $1.87 M | 0.00% | 1.27% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.89 M | $1.38 M | 992.29% | 0.94% |
PALE FIRE CAPITAL SE | 02/13/2025 | 1.40 M | $1.03 M | -12.53% | 0.70% |
SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 1.39 M | $1.02 M | -27.49% | 0.69% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 1.27 M | $934,000 | 150.87% | 0.63% |
UBS OCONNOR LLC | 02/14/2025 | 1.26 M | $928,039 | -18.39% | 0.63% |
UBS GROUP AG | 02/14/2025 | 923,060 | $677,526 | 253.49% | 0.46% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 797,411 | $584,981 | 535.37% | 0.40% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 650,000 | $476,840 | 3.99% | 0.32% |
JANE STREET GROUP, LLC | 02/14/2025 | 583,483 | $428,043 | 134.85% | 0.29% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 477,638 | $350,395 | 63.25% | 0.24% |
JPMORGAN CHASE & CO | 02/12/2025 | 459,653 | $337,202 | 501.04% | 0.23% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 438,208 | $321,469 | 0.00% | 0.22% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 344,747 | $252,906 | 0.00% | 0.17% |
DEUTSCHE BANK AG\ | 02/14/2025 | 267,628 | $195,369 | 559.56% | 0.13% |
BARCLAYS PLC | 02/13/2025 | 266,157 | $196,000 | -4.15% | 0.13% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 258,759 | $189,826 | -28.76% | 0.13% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 233,500 | $170,455 | 70.69% | 0.12% |
SIMPLEX TRADING, LLC | 02/11/2025 | 191,904 | $140,000 | 5,454.38% | 0.10% |
RHUMBLINE ADVISERS | 01/30/2025 | 178,725 | $131,174 | 0.14% | 0.09% |
KNOTT DAVID M JR | 02/12/2025 | 154,071 | $113,026 | 0.00% | 0.08% |
CITIGROUP INC | 02/12/2025 | 137,207 | $100,655 | 9.70% | 0.07% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 109,570 | $80,381 | 0.00% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 96,397 | $70,717 | 4.48% | 0.05% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 83,544 | $61,288 | -7.02% | 0.04% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 78,518 | $57,601 | 51.71% | 0.04% |
STIFEL FINANCIAL CORP | 02/13/2025 | 75,607 | $55,466 | -38.25% | 0.04% |
VONTOBEL HOLDING LTD. | 01/30/2025 | 75,000 | $55,020 | 0.00% | 0.04% |
INVESCO LTD. | 02/13/2025 | 62,073 | $45,537 | -49.85% | 0.03% |
ATRIA WEALTH SOLUTIONS, INC. | 01/31/2025 | 60,000 | $44,016 | 100.00% | 0.03% |
VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 58,702 | $43,064 | 0.00% | 0.03% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 55,996 | $41,000 | 0.00% | 0.03% |
NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 51,639 | $38,000 | 0.00% | 0.03% |
PROSHARE ADVISORS LLC | 02/14/2025 | 47,325 | $34,719 | -25.48% | 0.02% |
TD WATERHOUSE CANADA INC. | 02/13/2025 | 45,000 | $33,525 | 0.00% | 0.02% |
CANTOR FITZGERALD, L. P. | 02/14/2025 | 40,251 | $29,528 | 100.00% | 0.02% |
WOLVERINE TRADING, LLC | 02/14/2025 | 39,663 | $32,052 | 100.00% | 0.02% |
02/11/2025 | 33,784 | $24,784 | 100.00% | 0.02% | |
PNC FINANCIAL SERVICES GROUP, INC. | 02/07/2025 | 30,158 | $22,136 | 0.00% | 0.02% |
INTEGRATED WEALTH CONCEPTS LLC | 02/14/2025 | 30,000 | $22,008 | 100.00% | 0.01% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 29,301 | $21,495 | -28.03% | 0.01% |
X4 Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 121 institutional investors and hedge funds held shares of X4 Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Bain Capital Life Sciences Investors, LLC: 16.92 M
NEA Management Company, LLC: 14.99 M
BlackRock Funding, Inc. /DE: 11.06 M
VANGUARD GROUP INC: 8.2 M
ORBIMED ADVISORS LLC: 7.13 M
KINGDON CAPITAL MANAGEMENT, L.L.C.: 4.94 M
49.68% of X4 Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 100.78 M shares in the last 24 months. This purchase volume represents approximately $74.58 M in transactions.